Go to aakp.no
A PROGRAM IN

Omega-3 supplementation linked to cardiovascular health

A study by GOED shows that EPA/DHA supplementation is associated with major reductions in cardiovascular outcomes.

Blue Legasea
oil-capsel.jpg

Over the past few years, eicosapentaenoic (EPA) and docosahexaenoic (DHA) supplementations have shown beneficial effects for the prevention of cardiovascular diseases (CVD). In their last Meta-analysis including 40 studies (135 267 participants) published in the journal Mayo Clinic Proceedings, GOED linked significantly EPA/DHA supplementation with major reduction in cardiovascular outcomes:

  • 35% reduced risk of fatal myocardial infarction (MI)
  • 13% reduced risk of MI
  • 10% reduced risk of coronary heart disease (CHD) events
  • 9% reduced risk of CHD mortality
  • 5.8% reduction in the risk of CVD events
  • 9.0% reduction in the risk of MI

Moreover, the protective effects of EPA + DHA supplementation appears to increase with dosage and each additional 1g/day is associated with:

Considering that 80% of world population have low EPA and DHA levels and omega-3 are rarely obtained in most Westernized diets, food supplements appear reasonable alternatives to increase omega-3 intake. 

Read more about the study: